The Role of Olive Oil in the Treatment of Covid-19 Pneumonia

NCT06677658 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2024-11-07

No results posted yet for this study

Summary

Objective: Consuming natural olive oil in patients diagnosed with COVID-19 Pneumonia may strengthen immunity, slow down disease progression, and lower mortality. Within the scope of this research, the investigators aimed to elucidate the effect of using natural olive oil on clinical, laboratory, and radiological findings and survival in patients diagnosed with COVID-19 pneumonia and given pulse steroid treatment.

Method: This retrospective observational research enrolled 130 patients diagnosed with COVID-19 pneumonia. Participants were examined in two groups according to their olive oil consumption status. Patients diagnosed with COVID-19 pneumonia treated with pulse steroids for three days who routinely consumed oral olive oil in their daily diets were defined as Group 1, and those who did not consume olive oil were defined as Group 2.

Conditions

Interventions

DIETARY_SUPPLEMENT

Olive Oil

Group 1 included patients who consumed at least 20 ml of oral olive oil daily. Group 2 included patients who did not consume olive oil.

DRUG

Methylprednisolone

Both groups were diagnosed with Covid-19 pneumonia and were given pulse steroid ( methylprednisolone ) treatment at 250 mg/day for 3 days.

Sponsors & Collaborators

  • Giresun University

    lead OTHER

Principal Investigators

  • Selda Günaydın, MD · Assistant researcher

  • Ersin Kuloğlu, MD · Assistant researcher

  • Gökhan Aydın, MD · Assistant researcher

Eligibility

Min Age
27 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-06-01
Completion
2022-09-07

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06677658 on ClinicalTrials.gov